Accessed June 2019
Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Of those who responded, 87.7% report seeing at least one benefit
Research-Grade Quality: Supplied as a stable lyophilized powder for precise reconstitution
But it generally involves your healthcare provider submitting a form demonstrating that Wegovy is a medically necessary treatment option for you